AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionWhite Pine Investment CO
Latest Disclosed Ownership1,203 shares
Latest Disclosed Value $ 262
White Pine Investment CO reports 21.32% decrease in ownership of 4AB / AbbVie Inc.

On April 20, 2026 - White Pine Investment CO filed a 13F-HR form disclosing ownership of 1,203 shares of AbbVie Inc. (BG:4AB) valued at $262 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 1,529 shares of AbbVie Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F AbbVie US BRD MKT ETF 00287Y109 1,203 -326 -21.32 0 0.0609
2026-01-28 2025-12-31 13F AbbVie US BRD MKT ETF 00287Y109 1,529 0 0.00 0 0.0822
2025-10-14 2025-09-30 13F AbbVie US BRD MKT ETF 00287Y109 1,529 7 0.46 0 0.0840
2025-07-17 2025-06-30 13F AbbVie US BRD MKT ETF 00287Y109 1,522 0 0.00 0 0.0706
2025-04-23 2025-03-31 13F AbbVie US BRD MKT ETF 00287Y109 1,522 0 0.00 0 0.0859
2025-01-17 2024-12-31 13F AbbVie US BRD MKT ETF 00287Y109 1,522 0 0.00 0 0.0729
2024-10-29 2024-09-30 13F AbbVie US BRD MKT ETF 00287Y109 1,522 0 0.00 0 0.0826
2024-07-24 2024-06-30 13F AbbVie US BRD MKT ETF 00287Y109 1,522 -137 -8.26 0 0.0767
2024-04-26 2024-03-31 13F AbbVie COM 00287Y109 1,659 -50 -2.93 0 0.0892
2024-01-26 2023-12-31 13F AbbVie COM 00287Y109 1,709 0 0.00 0 0.0855
2023-10-27 2023-09-30 13F AbbVie COM 00287Y109 1,709 0 0.00 0 0.0896
2023-08-04 2023-06-30 13F AbbVie COM 00287Y109 1,709 0 0.00 0 0.0793
2023-04-14 2023-03-31 13F AbbVie COM 00287Y109 1,709 0 0.00 0 0.0977
2023-02-03 2022-12-31 13F AbbVie COM 00287Y109 1,709 117 7.35 0 -100.00 0.1050
2022-10-28 2022-09-30 13F AbbVie COM 00287Y109 1,592 0 0.00 214 -12.30 0.0886
2022-07-29 2022-06-30 13F AbbVie COM 00287Y109 1,592 0 0.00 244 -5.43 0.0964
2022-05-06 2022-03-31 13F AbbVie COM 00287Y109 1,592 0 0.00 258 19.44 0.0876
2022-01-28 2021-12-31 13F AbbVie COM 00287Y109 1,592 1,592 216 0.0719
2021-01-22 2020-12-31 13F AbbVie COM 00287Y109 0 -2,700 -100.00 0 -100.00
2020-11-02 2020-09-30 13F AbbVie COM 00287Y109 2,700 0 0.00 236 -10.94 0.1086
2020-08-13 2020-06-30 13F AbbVie COM 00287Y109 2,700 0 0.00 265 28.64 0.1308
2020-04-23 2020-03-31 13F AbbVie COM 00287Y109 2,700 100 3.85 206 -10.43 0.1180
2020-01-27 2019-12-31 13F AbbVie COM 00287Y109 2,600 2,600 230 0.0943
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.